ACE inhibitors are the most widely recognized medications that cause coughing, with roughly one in five patients stopping them because of it. But the list of cough-inducing drugs extends well beyond blood pressure pills, reaching into heart rhythm medications, antibiotics, cancer treatments, and even inhaled therapies meant to help you breathe. The mechanisms differ from one drug class to another, ranging from chemical irritation of airway nerves to actual damage of lung tissue.
ACE Inhibitors Are the Most Common Culprit
ACE inhibitors (drugs like lisinopril, enalapril, and ramipril) are prescribed to millions of people for high blood pressure and heart failure. They are also the single most common drug class linked to chronic cough. About one in five patients ends up discontinuing an ACE inhibitor because of cough and related side effects.1PubMed Central. Angiotensin-Converting Enzyme Inhibitors Induce Cough
The cough is typically dry, persistent, and sometimes described as a tickle or scratch in the throat. It does not produce mucus. The leading explanation involves a substance called bradykinin. ACE inhibitors block the enzyme that normally breaks down bradykinin, so levels of it build up in lung tissue. Bradykinin irritates sensory nerve endings in the airways, triggering the cough reflex. Research has confirmed that genetic variations in the bradykinin receptor influence who develops this side effect and who doesn’t.2PubMed. Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough
What makes this cough tricky to identify is its unpredictable timing. It can start within hours of the first pill or not appear until months into treatment. Once you stop the medication, the cough usually clears up within one to four weeks, though it can linger for as long as three months in some people.3PubMed. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines That wide onset window is exactly why many people and their doctors never connect the cough to the drug, especially when it shows up months after starting.
Why Women and Certain Populations Are More Affected
Not everyone on an ACE inhibitor gets a cough. Across studies, women are consistently more likely to develop it than men, and part of the reason appears to be genetic. Research has identified several genes involved. Variations in genes related to bradykinin receptors, an enzyme called neprilysin that also degrades bradykinin, and even the ACE gene itself all influence susceptibility. In one study, a specific ACE gene variant had opposite effects depending on sex: it was protective in men but increased risk in women.4PubMed. Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough
Separate work on the bradykinin receptor gene found that people carrying certain variants produce more bradykinin receptor protein, which ramps up airway sensitivity.2PubMed. Bradykinin B(2) receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough These genetic and sex-based differences partly explain why ACE inhibitor cough rates vary across populations. East Asian populations, for example, have historically reported higher cough rates than European populations, a pattern that aligns with the distribution of relevant gene variants. The science here is advancing toward the possibility of predicting in advance who will tolerate an ACE inhibitor and who won’t, though routine genetic testing for this isn’t standard practice yet.
Switching to an ARB or Other Alternative
When an ACE inhibitor causes a bothersome cough, the standard move is to switch to an ARB (angiotensin receptor blocker, such as losartan or valsartan). ARBs work on the same blood pressure pathway but do not block the breakdown of bradykinin, which is why they cause far less coughing. A large systematic review and meta-analysis found that ACE inhibitors carried roughly three times the cough risk compared to ARBs, and about five times the risk compared to calcium channel blockers.5PubMed Central. Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis
In practice, patients who develop any dry cough on an ACE inhibitor are often switched to an ARB regardless of how severe the cough is.6PubMed. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? This can sometimes be overly hasty, since not every cough in someone taking an ACE inhibitor is actually caused by the drug. Allergies, postnasal drip, and asthma are common enough that they deserve consideration before automatically blaming the medication. Still, if the cough started after beginning the ACE inhibitor and no other explanation fits, a trial switch to an ARB is reasonable and usually resolves the problem.
Beta-Blockers and Airway Tightening
Beta-blockers (like propranolol, atenolol, and metoprolol) are used for high blood pressure, heart failure, and irregular heart rhythms. They can cause coughing and breathing difficulty by a completely different route than ACE inhibitors: they block receptors in the airways that normally help keep the surrounding muscles relaxed. When those receptors are blocked, the airways can narrow.
This is a much bigger concern for people with asthma or chronic obstructive pulmonary disease. In someone with healthy lungs, the effect is usually mild or unnoticeable. But in someone with reactive airways, a beta-blocker can trigger wheezing, coughing, and full-blown asthma flares. Even beta-blocker eye drops used for glaucoma can do this. A meta-analysis found that non-selective beta-blocker eye drops caused lung function to drop by about 11% on average in people with asthma, with roughly one in three experiencing a clinically meaningful decrease.7PubMed Central. Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials Asthma exacerbations and bronchospasm from these eye drops have been well documented for decades.8PubMed. Pulmonary complications from ophthalmic preparations
Cardioselective beta-blockers, those that preferentially target heart receptors over lung receptors, tend to be safer for the airways, though even they carry some risk in people with severe airway disease. If you have asthma and are prescribed a beta-blocker for any reason, including as eye drops, this is worth raising with your doctor.
Calcium Channel Blockers and Reflux-Related Cough
Calcium channel blockers (like amlodipine, nifedipine, and diltiazem) do not directly irritate the airways the way ACE inhibitors or beta-blockers can. But they can cause coughing through a roundabout path: they relax the muscular valve at the bottom of the esophagus. When that valve loosens, stomach acid creeps upward, causing gastroesophageal reflux. Reflux is one of the top three causes of chronic cough. Calcium channel blockers increase the esophagus’s exposure to stomach acid and reduce the strength of the normal wave-like contractions that push acid back down.9PubMed Central. Calcium Channel Brokers and Esophageal Sclerosis: Should We Expect Exacerbation of Interstitial Lung Disease?
This means a cough caused by a calcium channel blocker often comes with other reflux symptoms like heartburn or a sour taste, though reflux can also provoke coughing without any obvious heartburn. If you develop a new cough on a calcium channel blocker and notice it worsens after meals or when lying down, reflux is a plausible explanation. The cough here isn’t really a “side effect of the drug on the lungs” so much as a side effect on the esophagus that cascades into a lung symptom.
Amiodarone and Lung Toxicity
Amiodarone is a powerful antiarrhythmic drug used to control dangerous heart rhythms, particularly atrial fibrillation. Unlike most medications on this list, amiodarone can actually damage lung tissue. Pulmonary toxicity occurs in roughly 1% to 5% of patients, and the most common form is interstitial pneumonitis, an inflammation of the tissue between the air sacs in the lungs. Patients typically present with worsening shortness of breath, a dry cough, and sometimes fever, which makes it easy to confuse with pneumonia or worsening heart failure.10PubMed Central. Amiodarone-Induced Interstitial Pneumonia: A Cause of Respiratory Failure
In one documented case, a patient developed lung toxicity after two years on a standard 200 mg daily maintenance dose, presenting with progressive shortness of breath, a nonproductive cough, and new dependence on supplemental oxygen.11PubMed Central. Amiodarone-Induced Pulmonary Toxicity in an Elderly Patient: A Case Report The risk increases with higher doses and longer treatment, but as that case illustrates, it can happen even at standard doses. When amiodarone is stopped and appropriate treatment is started, the lung inflammation often improves, though severe cases can cause permanent scarring.
Antibiotics That Can Affect the Lungs
Most antibiotics do not cause coughing, but a notable exception is nitrofurantoin, a drug commonly used for urinary tract infections. It has been associated with rare but serious pulmonary reactions that take two very different forms depending on how long you’ve been taking it. An acute reaction resembles an allergic response: fever, shortness of breath, and elevated eosinophils in the blood, usually resolving quickly once the drug is stopped. A chronic reaction, which develops in people who take nitrofurantoin for months as a preventive measure against recurrent infections, can lead to progressive scarring of the lungs that may not fully reverse.12PubMed Central. Nitrofurantoin-Induced Pulmonary Toxicity: Mechanisms, Diagnosis, and Management
The acute form is more common and less dangerous, while the chronic form is rarer but far more concerning. If you’re on long-term nitrofurantoin and develop a new cough or increasing shortness of breath, it warrants prompt medical evaluation rather than a wait-and-see approach.
Anti-Inflammatory and Immune-Modifying Drugs
Methotrexate, widely used for rheumatoid arthritis and other autoimmune conditions, can cause a persistent cough that sometimes signals the beginning of drug-induced pneumonitis. In that setting, the cough appears alongside worsening shortness of breath, general malaise, decreased lung function, and changes visible on a chest X-ray.13PubMed. Sustained cough in methotrexate therapy for rheumatoid arthritis The cough itself is not dangerous, but it can be an early warning sign that lung inflammation is developing. Anyone on methotrexate who develops a new persistent cough should bring it up at their next appointment rather than brushing it off as a cold.
Cancer Treatments
Several cancer therapies cause cough through direct lung injury, and the mechanisms differ across drug types.
Bleomycin, a chemotherapy drug used in lymphoma and testicular cancer regimens, is notorious for lung toxicity. Dry cough and shortness of breath are the typical first symptoms of bleomycin-induced pneumonitis.14PubMed. Severe bleomycin-induced pneumonitis: Clinical features and response to corticosteroids The risk climbs with higher cumulative doses, and patients receiving bleomycin are monitored for declining lung function throughout treatment. Supplemental oxygen, which most people think of as harmless, can actually worsen bleomycin lung injury, a detail that matters during surgical procedures involving anesthesia.
Newer immunotherapies have introduced a different mechanism entirely. Immune checkpoint inhibitors (drugs like pembrolizumab, nivolumab, and ipilimumab) work by releasing the brakes on the immune system so it can attack cancer cells. A consequence of that unleashed immune response is that it sometimes also attacks healthy tissue, including lung tissue. Roughly 40% of patients on these drugs experience some form of immune-related side effect, and while lung inflammation is not the most common one, it carries a threefold increased risk of requiring intensive care.15PubMed Central. Immune Checkpoint Inhibitor-associated Pneumonitis: A Narrative Review
Antibody-drug conjugates, a newer category of targeted cancer therapy, carry similar lung risks. In a study of patients receiving trastuzumab deruxtecan for various solid tumors, nearly all who developed pneumonitis presented with cough.16PubMed Central. Trastuzumab Deruxtecan-Associated Pneumonitis in Non-Breast Solid Tumors: A Retrospective Cohort Study As this class of drugs expands to treat more cancer types, awareness of their lung risks is growing alongside their use.
Inhaled Medications
There is a frustrating irony in the fact that drugs designed to treat breathing problems can themselves provoke coughing. Inhaled medications for asthma and COPD, including corticosteroids, bronchodilators, and combination inhalers, frequently trigger cough during or immediately after use. The cough in this case is usually not a sign of toxicity. It results from the physical or chemical properties of the aerosol: the particle size, the pH, the propellant, the preservatives, or the cold blast of spray hitting sensitive airways. In diseased airways where bronchoconstriction is already present, this effect is amplified, and the resulting cough actually reduces how much drug reaches the lungs.17PubMed Central. Cough as an adverse effect on inhalation pharmaceutical products
The practical fix is often straightforward: switching inhaler types (from a dry powder inhaler to a metered-dose inhaler or vice versa), improving inhalation technique, or adding a spacer device to the inhaler. These changes alter the speed, temperature, and particle distribution of the aerosol enough to reduce airway irritation for most people. If your inhaler makes you cough every time you use it, bringing this up with your prescriber is worthwhile rather than just powering through it.
Figuring Out If Your Medication Is the Cause
Sorting out whether a cough is drug-related or caused by something else requires some detective work. A few features make a medication-related cough more likely:
- Timing: The cough started after beginning a new medication or changing the dose. With ACE inhibitors, this window can range from hours to several months, which is why the connection is sometimes missed entirely.3PubMed. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines
- Character: Drug-induced cough is almost always dry and nonproductive. A cough that brings up colored mucus points more toward infection or sinus drainage.
- Persistence: The cough does not respond to typical treatments like cough suppressants, antihistamines, or antibiotics for presumed infections.
- Resolution: If the cough disappears or improves within a few weeks of stopping the suspected drug, the connection is strong.
When lung-toxic medications like amiodarone, methotrexate, or bleomycin are involved, a new cough warrants prompt evaluation because it could indicate developing lung damage rather than simple airway irritation. Imaging and lung function testing may be needed in those situations. For medications where the cough is merely annoying rather than dangerous, as with ACE inhibitors, the solution is usually a straightforward medication switch.
Inactive Ingredients as Overlooked Triggers
Most conversations about drug-induced cough focus on the active ingredient, but inactive ingredients in a medication’s formulation can occasionally play a role. Preservatives, flavorings, dyes, and fillers make up the bulk of many pills and liquids, and they sometimes cause irritant or allergic reactions. This is part of why two people taking the same active drug from different manufacturers sometimes report different side effects: the drug molecule is identical, but everything surrounding it differs.
The issue is especially relevant for inhaled drugs, where excipients are delivered directly into the airways and can interact with cough-triggering nerve endings. But it can also matter for oral medications in sensitive individuals. If you develop a cough after switching from one manufacturer’s version of a drug to another, the excipient profile is worth examining with your pharmacist. These reactions are uncommon, and the active ingredient remains the far more likely culprit in most cases, but excipient sensitivity is a real and underappreciated phenomenon that can be solved simply by switching brands.